JPM26: Danaher positioned to improve patient diagnostics [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
This outlook really shaped the company's future plans with devices and investment. There was a strong emphasis on adopting new technologies to improve diagnostic accuracy and speed. Rainer Blaire, CEO of Danaher, highlighted that Danaher is well positioned in 2026 with high single digit growth since the company's diagnostic portfolio is in highly attractive areas such as molecular testing, pathology and blood gas, and in core lab. The presentation highlighted that Beckman Coulter's Dxl 9000 Immunoassay Analyzer as an innovative solution for healthcare's biggest challenges as the device leads in workflow and 100 times more sensitivity compared to other devices on the market. Rainer Blaire emphasized that the Dxl 9000 would improve diagnosis of more sensitive diseases like Alzheimer's in early stages and other complex illnesses in standard hospitals. Thus, streamlining care for patients earlier on since diagnostic tests would be more accessible. Danaher is poised to continue to exc
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Danaher (DHR) Rebounded on Accelerated Demand [Yahoo! Finance]Yahoo! Finance
- How Investors Are Reacting To Danaher (DHR) Upbeat 2025 Outlook And Growing Synthetic Biology Ambitions [Yahoo! Finance]Yahoo! Finance
- X-Rite and Rhopoint Launch Rhopoint PANTORA Aesthetix® to Streamline Creation of Digital Material Twins [Yahoo! Finance]Yahoo! Finance
- Danaher (NYSE:DHR) was given a new $265.00 price target on by analysts at Argus.MarketBeat
- Integrated DNA Technologies Invests in New Research, Development and Innovation Center in San Francisco Bay Area [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 10/21/25 - Beat
DHR
Sec Filings
- 1/12/26 - Form 8-K
- 12/31/25 - Form 4
- 11/26/25 - Form 4
- DHR's page on the SEC website